Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Long-term prognostic significance of response in multiple myeloma after stem cell transplantation

Autor: Martinez-Lopez, Joaquin, Blade, Joan, Mateos, María-Victoria, Grande, Carlos, Alegre, Adrián, García-Laraña, José, Sureda, Anna, de la Rubia, Javier, Conde, Eulogio, Martinez, Rafael, de Arriba, Felipe, Viguria, Maria C., Besalduch, Joan, Cabrera, Rafael, Gonzalez-San Miguel, José D., Guzman-Zamudio, José Luis, Gomez del Castillo, Maria Carmen, Moraleda, José Maria, García-Ruiz, Juan C., San Miguel, Jesús, Lahuerta, Juan José

Publikováno v: In Blood 21 July 2011 118(3):529-534

Allogeneic hematopoietic stem cell transplantation in patients with multiple myeloma. Impact of disease characteristics, disease status at transplant, and prior number of lines of therapy. Results of retrospective, multicentre Spanish study.

Autor: Rubia, Javier De La, Pérez, Ariadna, Rosinol, Laura, Arnao, Mario, Teruel, Ana Isabel, Herrera, Inmaculada, Albo, Carmen, Vaz, Carlos, Krisnk, Isabel, Bermudez, Arancha, Pascual, María J., Encinas, Cristina, Cabanas, Valentín, Jurado, Manuel, Gonzalez, Sonia, Viguria, Maria C., Chinea, Anabelle, Ferra, Christelle, Sampol, Antonia, Solano, Carlos, Gonzalez, Marta S.

Publikováno v: In Clinical Lymphoma, Myeloma and Leukemia October 2019 19(10) Supplement:e289-e290

A new prognostic model identifies patients aged 80 years and older with diffuse large B-cell lymphoma who may benefit from curative treatment: A multicenter, retrospective analysis by the Spanish GELTAMO group.

Autor: Pardal E; Hematology Department, Hospital Virgen del Puerto, Plasencia., Díez Baeza E; Hematology Department, Hospital Universitario de Salamanca- IBSAL, Centro de Investigación Biomédica en Red de Cáncer (CIBERONC), Salamanca., Salas Q; Hematology Department, ICO, Hospital Duran i Reynals, L'Hospitalet de Llobregat., García T; Hematology Department, Hospital Arnau de Vilanova, Lleida., Sancho JM; Hematology Department, ICO-IJC-Hospital Germans Trias i Pujol, Badalona., Monzón E; Hematology Department, Hospital Arnau de Vilanova, Valencia., Moraleda JM; Hematology Department, Hospital Universitario Virgen de La Arrixaca, University of Murcia, Murcia., Córdoba R; Hematology Department, Fundación Jiménez Díaz, Madrid., de la Cruz F; Hematology Department, Hospital Universitario Virgen del Rocío, IBIS/CSIC/Universidad de Sevilla, Seville., Queizán JA; Hematology Department, Hospital General de Segovia, Segovia., Rodríguez MJ; Hematology Department, Hospital Universitario de Canarias, La Laguna., Navarro B; Hematology Department, Hospital Universitario Puerta de Hierro, Madrid., Hernández JA; Hematology Department, Hospital Universitario Infanta Leonor, Universidad Complutense, Madrid., Díez R; Hematology Department, Hospital de Txagorritxu, Vitoria., Vahi M; Hematology Department, Hospital Nuestra Señora de Valme, Sevilla., Viguria MC; Hematology Department, Hospital de Navarra, Pamplona., Canales M; Hematology Department, Hospital de la Paz, Madrid., Peñarrubia MJ; Hematology Department, Hospital Clínico de Valladolid, Valladolid., González-López TJ; Hematology Department, Hospital Universitario de Burgos, Burgos., Montes-Moreno S; Department of Pathology / Laboratorio de Hematopatología Traslacional, IDIVAL, Hospital Universitario Marqués de Valdecilla, Santander., González-Barca E; Hematology Department, ICO, Hospital Duran i Reynals, L'Hospitalet de Llobregat., Caballero D; Hematology Department, Hospital Universitario de Salamanca- IBSAL, Centro de Investigación Biomédica en Red de Cáncer (CIBERONC), Salamanca., Martín A; Hematology Department, Hospital Universitario de Salamanca- IBSAL, Centro de Investigación Biomédica en Red de Cáncer (CIBERONC), Salamanca.

Publikováno v: American journal of hematology [Am J Hematol] 2018 Jul; Vol. 93 (7), pp. 867-873. Date of Electronic Publication: 2018 May 06.